Rationale for the development of alternative forms of androgen deprivation therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rationale for the development of alternative forms of androgen deprivation therapy
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 24, Issue 8, Pages R275-R295
Publisher
Bioscientifica
Online
2017-06-01
DOI
10.1530/erc-17-0121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
- (2017) Lei Wei et al. EUROPEAN UROLOGY
- Androgen Signaling in Prostate Cancer
- (2017) Charles Dai et al. Cold Spring Harbor Perspectives in Medicine
- TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
- (2016) Anna C. Groner et al. CANCER CELL
- Multivalent Peptoid Conjugates Which Overcome Enzalutamide Resistance in Prostate Cancer Cells
- (2016) Y. Wang et al. CANCER RESEARCH
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance
- (2016) Yang Zhan et al. MOLECULAR CANCER RESEARCH
- Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy
- (2016) Zhenfei Li et al. NATURE
- Gene regulatory mechanisms underpinning prostate cancer susceptibility
- (2016) Thomas Whitington et al. NATURE GENETICS
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
- (2016) J C Zhao et al. ONCOGENE
- Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth
- (2016) D Obinata et al. ONCOGENE
- Cell cycle-coupled expansion of AR activity promotes cancer progression
- (2016) C McNair et al. ONCOGENE
- Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
- (2016) Christine Henzler et al. Nature Communications
- Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines
- (2016) Stephen Wilson et al. Scientific Reports
- NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
- (2016) Collene R Jeter et al. Cell Discovery
- DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
- (2015) Jonathan F. Goodwin et al. CANCER CELL
- Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes
- (2015) D. Xu et al. CANCER RESEARCH
- Sequencing current therapies in the treatment of metastatic prostate cancer
- (2015) Loana B. Valenca et al. CANCER TREATMENT REVIEWS
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer
- (2015) Y. Yamamoto et al. CLINICAL CANCER RESEARCH
- Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
- (2015) Paul L. Nguyen et al. EUROPEAN UROLOGY
- Genomic Predictors of Outcome in Prostate Cancer
- (2015) Peter J. Boström et al. EUROPEAN UROLOGY
- Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
- (2015) Theodoros Karantanos et al. EUROPEAN UROLOGY
- Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
- (2015) Zhenfei Li et al. NATURE
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
- (2015) Mark M Pomerantz et al. NATURE GENETICS
- Targeting the MLL complex in castration-resistant prostate cancer
- (2015) Rohit Malik et al. NATURE MEDICINE
- Are androgen receptor variants a substitute for the full-length receptor?
- (2015) Ji Lu et al. Nature Reviews Urology
- Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
- (2015) Siu Chiu Chan et al. NUCLEIC ACIDS RESEARCH
- Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer
- (2015) Sindy Magnan et al. JAMA Oncology
- SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin
- (2015) Sari Toropainen et al. NUCLEIC ACIDS RESEARCH
- Tumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide
- (2015) Amanda E. Hargrove et al. PLoS One
- PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
- (2015) Martin Puhr et al. Oncotarget
- Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy
- (2015) Bo Cao et al. Oncotarget
- Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1
- (2014) Y. Wang et al. CANCER RESEARCH
- Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer
- (2014) Z. Chen et al. EMBO JOURNAL
- TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer
- (2014) Stefan Steurer et al. EUROPEAN UROLOGY
- Targeting Androgen Receptor Action for Prostate Cancer Treatment: Does the Post-Receptor Level Provide Novel Opportunities?
- (2014) Hannelore V. Heemers International Journal of Biological Sciences
- Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer
- (2014) Kush Dalal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo
- (2014) Biswajyoti Sahu et al. NUCLEIC ACIDS RESEARCH
- Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
- (2014) Dayong Wu et al. NUCLEIC ACIDS RESEARCH
- The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
- (2014) Naomi L. Sharma et al. NUCLEIC ACIDS RESEARCH
- GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
- (2014) Bin He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens
- (2014) C. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Promoter-Dependent Activity on Androgen Receptor N-Terminal Domain Mutations in Androgen Insensitivity Syndrome
- (2014) Rieko Tadokoro-Cuccaro et al. Sexual Development
- Lysine-Specific Demethylase 1 Has Dual Functions as a Major Regulator of Androgen Receptor Transcriptional Activity
- (2014) Changmeng Cai et al. Cell Reports
- Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
- (2014) Jian An et al. Cell Reports
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- The E3 Ubiquitin Ligase Siah2 Contributes to Castration-Resistant Prostate Cancer by Regulation of Androgen Receptor Transcriptional Activity
- (2013) Jianfei Qi et al. CANCER CELL
- USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression
- (2013) R. S. Schrecengost et al. CANCER RESEARCH
- Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes
- (2013) S. Balasubramaniam et al. CLINICAL CANCER RESEARCH
- Genome-Wide Integrated Analyses of Androgen Receptor Signaling in Prostate Cancer Based on High-Throughput Technology
- (2013) Kuniko Horie-Inoue et al. CURRENT DRUG TARGETS
- Androgen Receptor: Past, Present and Future
- (2013) Lucy J. Schmidt et al. CURRENT DRUG TARGETS
- ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
- (2013) E. Baena et al. GENES & DEVELOPMENT
- An androgen receptor N-terminal domain antagonist for treating prostate cancer
- (2013) Jae-Kyung Myung et al. JOURNAL OF CLINICAL INVESTIGATION
- AKR1C3 as a target in castrate resistant prostate cancer
- (2013) Adegoke O. Adeniji et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
- (2013) Yu Chen et al. NATURE MEDICINE
- Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
- (2013) C. Geng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer
- (2013) Preethi Ravindranathan et al. Nature Communications
- A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult
- (2013) J. F. Goodwin et al. Cancer Discovery
- The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
- (2012) Naomi L. Sharma et al. CANCER CELL
- FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
- (2012) B. Sahu et al. CANCER RESEARCH
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
- (2012) Himisha Beltran et al. EUROPEAN UROLOGY
- The androgen receptor gene mutations database: 2012 update
- (2012) Bruce Gottlieb et al. HUMAN MUTATION
- Multivalent Peptidomimetic Conjugates: A Versatile Platform for Modulating Androgen Receptor Activity
- (2012) Paul M. Levine et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
- Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
- (2012) J. R. Prensner et al. Science Translational Medicine
- Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity
- (2012) Alok K Tewari et al. GENOME BIOLOGY
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
- (2011) Changmeng Cai et al. CANCER CELL
- Analysis of the Human Endogenous Coregulator Complexome
- (2011) Anna Malovannaya et al. CELL
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- Pioneer transcription factors: establishing competence for gene expression
- (2011) K. S. Zaret et al. GENES & DEVELOPMENT
- Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells
- (2011) Irina Ianculescu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival
- (2011) P. Y. Tan et al. MOLECULAR AND CELLULAR BIOLOGY
- Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1
- (2011) Ying Wang et al. MOLECULAR ENDOCRINOLOGY
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
- (2011) C R Jeter et al. ONCOGENE
- Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
- (2011) A Urbanucci et al. ONCOGENE
- Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure
- (2011) Alfonso Urbanucci et al. PROSTATE
- A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities
- (2011) Rong Hu et al. PROSTATE
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
- (2010) Raymond J. Andersen et al. CANCER CELL
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
- (2010) Ankur Sharma et al. JOURNAL OF CLINICAL INVESTIGATION
- Testing mutual exclusivity of ETS rearranged prostate cancer
- (2010) Maria A Svensson et al. LABORATORY INVESTIGATION
- Phosphorylation of histone H3T6 by PKCβI controls demethylation at histone H3K4
- (2010) Eric Metzger et al. NATURE
- Nucleosome dynamics define transcriptional enhancers
- (2010) Housheng Hansen He et al. NATURE GENETICS
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Regulation of Androgen Receptor Transcriptional Activity and Specificity by RNF6-Induced Ubiquitination
- (2009) Kexin Xu et al. CANCER CELL
- Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?
- (2009) Gerhardt Attard et al. CANCER CELL
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
- (2009) John David Norris et al. CHEMISTRY & BIOLOGY
- Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP
- (2009) A. R. Karpf et al. MOLECULAR CANCER RESEARCH
- The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens
- (2009) John D. Norris et al. MOLECULAR CELL
- Androgen Modulation of Coregulator Expression in Prostate Cancer Cells
- (2009) Hannelore V. Heemers et al. MOLECULAR ENDOCRINOLOGY
- ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
- (2009) Y. Zong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity
- (2009) S. H. Meijsing et al. SCIENCE
- Functional Evidence that the Self-Renewal GeneNANOGRegulates Human Tumor Development
- (2009) Collene R. Jeter et al. STEM CELLS
- Androgen Receptor Overexpression in Prostate Cancer Linked to Pur Loss from a Novel Repressor Complex
- (2008) L. G. Wang et al. CANCER RESEARCH
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
- (2008) J. Wang et al. CANCER RESEARCH
- Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer
- (2008) Yi Peng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A causal role for ERG in neoplastic transformation of prostate epithelium
- (2008) O. Klezovitch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
- (2008) Scott A. Tomlins et al. NEOPLASIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started